- Report
- December 2024
- 100 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- October 2025
- 197 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- March 2025
- 175 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- August 2025
- 154 Pages
Global
From €2594EUR$2,900USD£2,282GBP
- Report
- July 2025
- 150 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- December 2024
- 110 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- October 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 196 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 182 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 186 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 196 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 182 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 199 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 186 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 185 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 270 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- October 2025
- 340 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €894EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €894EUR$1,000USD£787GBP
€1118EUR$1,250USD£983GBP
- Report
- May 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,029GBP
€4338EUR$4,850USD£3,816GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more